Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy

Transferrin Receptor 2 Is Frequently and Highly Expressed in Glioblastomas

(2014) Alessia Calzolari et al.   Translational Oncology

The Role of Surface Functionality in Determining Nanoparticle Cytotoxicity

(2013) Sung Tae Kim et al.   ACCOUNTS OF CHEMICAL RESEARCH

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status

(2013) Roy van der Meel et al.   ADVANCED DRUG DELIVERY REVIEWS

Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles

(2013) Yanyu Huang et al.   BIOMATERIALS

Transferrin-Modified Doxorubicin-Loaded Biodegradable Nanoparticles Exhibit Enhanced Efficacy in Treating Brain Glioma-Bearing Rats

(2013) Guodong Liu et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery

(2013) Joung-Pyo Nam et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Surface functionalization of nanoparticles for nanomedicine

(2012) Rubul Mout et al.   CHEMICAL SOCIETY REVIEWS

Therapeutic targets and recent advances in protein immunotoxins

(2012) Madhumathi J et al.   CURRENT OPINION IN MICROBIOLOGY

Enhanced antitumor efficacy of cisplatin by tirapazamine–transferrin conjugate

(2012) Lin Wu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting

(2012) Tae Hyung Kim et al.   JOURNAL OF CONTROLLED RELEASE

The intracellular trafficking pathway of transferrin

(2011) Kristine M. Mayle et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Therapeutic potential of anticancer immunotoxins

(2011) Swati Choudhary et al.   DRUG DISCOVERY TODAY

Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines

(2011) A. Cimini et al.   JOURNAL OF CELLULAR PHYSIOLOGY

In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin Receptor

(2011) S. Paris-Robidas et al.   MOLECULAR PHARMACOLOGY

Transferrin Adsorption onto PLGA Nanoparticles Governs Their Interaction with Biological Systems from Blood Circulation to Brain Cancer Cells

(2011) Jiang Chang et al.   PHARMACEUTICAL RESEARCH

Small GTPase Rab12 Regulates Constitutive Degradation of Transferrin Receptor

(2011) Takahide Matsui et al.   TRAFFIC

Differential Expression of Transferrin Receptor (TfR) in a Spectrum of Normal to Malignant Breast Tissues

(2011) Meenakshi Singh et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Recombinant human transferrin: Beyond iron binding and transport

(2010) Martin E. Brandsma et al.   BIOTECHNOLOGY ADVANCES

A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro

(2010) W. WOITH et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Toxin-Based Therapeutic Approaches

(2010) Assaf Shapira et al.   Toxins

Real-Time Monitoring of Transferrin-Induced Endocytic Vesicle Formation by Mid-Infrared Surface Plasmon Resonance

(2009) Victor Yashunsky et al.   BIOPHYSICAL JOURNAL

Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA

(2009) Swati Koppu et al.   JOURNAL OF CONTROLLED RELEASE

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

(2008) Karsten Ulbrich et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins

(2008) Dennis J. Yoon et al.   JOURNAL OF CONTROLLED RELEASE